InsidersTradesSigma
네오팜 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 네오팜 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 네오팜 has published 23 reports. Market capitalisation: €262.9bn. The latest transaction was reported on 5 March 2026 (Purchase). Among the most active insiders: 잇츠한불. The full history is free.
23
Insider Decl.
0
Thresholds
€2m
17 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 616 of 26,153 companies
83.3
score / 100
Value79
Quality88
FCF yld9.3%
Earn yld9.6%
EV/EBITDA8.2x
ROE·
Gross mgn65%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2026
Declarations23 total
164,396 sharesKRXDART:20260305000589
Ideal exit: 13 Nov 2026 (T+270)
23 of 23 declarations